Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Schwann cell JUN expression worsens motor performance in an amyotrophic lateral sclerosis mouse model.

Glia·2024

Same author

Regulatory T cells limit age-associated retinal inflammation and neurodegeneration.

Molecular neurodegeneration·2024

Same author

Ageing impairs the regenerative capacity of regulatory T cells in mouse central nervous system remyelination.

Nature communications·2024

Same author

Glial cell alterations in diabetes-induced neurodegeneration.

Cellular and molecular life sciences : CMLS·2024

Same author

Novel therapeutic approaches to target neurodegeneration.

British journal of pharmacology·2023

Same author

Immune-stem cell crosstalk in the central nervous system: how oligodendrocyte progenitor cells interact with immune cells.

Immunology and cell biology·2022

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

Navigating the transition to Principal Investigator.

Alerie G de la Fuente^1,2

¹Institute of Health and Biomedical Research of Alicante (ISABIAL), Alicante, Spain.

Immunology and Cell Biology

|September 16, 2024

Summary

This summary is machine-generated.

Starting a research group as a new Principal Investigator (PI) is challenging. This reflection shares common hurdles and insights for early-career PIs navigating this critical career transition.

Keywords:

Academia Principal Investigator career starting your research group transition

More Related Videos

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

Transition of Farm Pigs to Research Pigs using a Designated Checklist followed by Initiation of Clicker Training - a Refinement Initiative

Transition of Farm Pigs to Research Pigs using a Designated Checklist followed by Initiation of Clicker Training - a Refinement Initiative

Published on: August 21, 2021

Related Experiment Videos

Last Updated: Jun 19, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

Transition of Farm Pigs to Research Pigs using a Designated Checklist followed by Initiation of Clicker Training - a Refinement Initiative

Transition of Farm Pigs to Research Pigs using a Designated Checklist followed by Initiation of Clicker Training - a Refinement Initiative

Published on: August 21, 2021

Area of Science:

Research Management
Principal Investigator Transition

Background:

Transitioning to Principal Investigator (PI) roles presents unique challenges.
Existing scientific training often lacks essential research group management skills.

Purpose of the Study:

To reflect on the personal experiences and mistakes made during the initial two years as a new PI.
To provide actionable insights for future PIs facing similar career transitions.

Main Methods:

Personal reflection on early-career Principal Investigator experiences.
Identification of common challenges encountered by new PIs.

Main Results:

New PIs face a steep learning curve beyond scientific expertise.
Specific skill gaps include personnel management, budgeting, and project oversight.
Proactive learning and mentorship are crucial for success.

Conclusions:

Successful navigation of the PI role requires developing new skill sets.
Sharing experiences can mitigate common pitfalls for incoming PIs.
Early-career support systems are vital for fostering independent research leaders.